114 Results

People

  1. Giralt
    Giralt
  2. Shah
    Shah
  3. Dahi
    Dahi
  4. Scordo
    Scordo
  5. Sadelain
    Sadelain
  6. Perales
    Perales
  7. Kharas
    Kharas
  8. Sauter
    Sauter
  9. Devlin
    Devlin
  10. Palomba
    Palomba

Groups

  1. Center for Hematologic Malignancies (114)
  2. Hematologic Malignancies Research (114)
  3. MSK Grad Students (114)
  4. GSK Faculty (101)
  5. Department of Medicine (84)
  6. Hematologic Malignancies, Division of (83)
  7. Sloan Kettering Institute Faculty (83)
  8. Sloan Kettering Institute Postdocs (78)
  9. Molecular Pharmacology and Chemistry Program Faculty (66)
  10. Tow Center for Developmental Oncology (TCDO) (54)
  1. "Hematologic Malignancies Research"
  2. "MSK Grad Students"
  3. "Meeting abstract"
Formats
  1. Meeting Abstract (114)
Groups
  1. Center for Hematologic Malignancies (114)
  2. Hematologic Malignancies Research (114)
  3. MSK Grad Students (114)
  4. GSK Faculty (101)
  5. Department of Medicine (84)
  6. Hematologic Malignancies, Division of (83)

More Groups

People
  1. Sergio Giralt (29)
  2. Gunjan Shah (25)
  3. Parastoo Dahi (24)
  4. Michael Scordo (23)
  5. Michel Sadelain (22)
  6. Miguel-Angel Perales (21)

More People

Years
  1. 2023 (11)
  2. 2022 (10)
  3. 2021 (12)
  4. 2020 (23)
  5. 2019 (16)
  6. 2018 (13)

More Years

Publications
  1. Blood (56)
  2. Cancer Research (9)
  3. Molecular Therapy (9)
  4. Biology of Blood and Marrow Transplantation (8)
  5. Clinical Lymphoma, Myeloma and Leukemia (5)
  6. Biophysical Journal (4)

More Publications

Publishers
  1. American Society of Hematology (56)
  2. Elsevier Inc. (14)
  3. American Association for Cancer Research (12)
  4. Nature Publishing Group (11)
  5. Cell Press (4)
  6. American Society of Clinical Oncology (3)

More Publishers

Results (114)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Responses and outcomes after second-line therapy in transplant-eligible patients with DLBCL relapse over 1 year after first-line therapy
    Meeting Abstract

    Qualls, D. A.; Shah, G. L.; Shouval, R.; Caron, P.; David, K. A.; Falchi, L.; Ghione, P.; Hamlin, P. A.; Horwitz, S. M.; Intlekofer, A. M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • m (6)A-SON-CCL5 axis controls HSC fate and inflammation
    Meeting Abstract

    Luo, H.; Cortés-López, M.; Tam, C. L.; Xiao, M.; Wakiro, I.; Chu, K. L.; Pierson, A.; Chan, M.; Chang, K.; Yang, X.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Stem cell utilization in the era of novel therapies for multiple myeloma
    Meeting Abstract

    Nishimura, N.; Nemirovsky, D.; Devlin, S. M.; Dahi, P. B.; Landau, H.; Lahoud, O. B.; Scordo, M.; Shah, G. L.; Mailankody, S.; Hassoun, H.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A phase II trial of prophylactic anakinra to prevent neurotoxicity in patients receiving anti-CD19 CAR T-cell therapy for relapsed or refractory lymphoma: Final results from cohort 2
    Meeting Abstract

    Nath, K.; Devlin, S. M.; Sauter, C. S.; Palomba, M. L.; Shah, G. L.; Dahi, P. B.; Lin, R. J.; Scordo, M.; Perales, M. A.; Leslie, L. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Synthetic dual-costimulation for TCR and TCR-like targeted cell therapies
    Meeting Abstract

    Dobrin, A.; Xie, H.; Perica, K.; Jain, N.; Sadelain, M.; Hamieh, M.
    Human Gene Therapy (2023)

    Fulltext@MSK | Save
  • Neopeptide diversity and similarity to the unmutated immunopeptidome is associated with response to immune checkpoint blockade therapy
    Meeting Abstract

    Klatt, M.; Molvi, Z.; Panageas, K.; Wells, D.; Hellmann, M.; Merghoub, T.; Wolchok, J.; O'Reilly, R.; Keller, U.; Scheinberg, D.
    Oncology Research and Treatment (2023)

    Fulltext@MSK | Save
  • Efficacy and safety of commercially approved BCMAtargeting CAR-T therapy in triple-class refractory multiple myeloma
    Meeting Abstract

    Nishimura, N.; Brown, S.; Sean, M. D.; Parastoo, D.; Heather, J. L.; Oscar, B. L.; Michael, S.; Gunjan, L. S.; David, J. C.; Hani, H.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • A radiohapten capture system for in vivo CAR T cell tracking in ovarian cancer
    Meeting Abstract

    Gajecki, L.; Eibler, L.; Kurtz, K.; Lovibond, S.; Veach, D.; Larson, S.; Scheinberg, D.; Krebs, S.
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save
  • Successful incorporation of ePRO using PROMIS-29 into standard of care after hematopoietic stem cell transplant and chimeric antigen receptor T cell therapy for plasma cell dyscrasias
    Meeting Abstract

    Shah, G.; Lobaugh, S.; Devlin, S.; Atkinson, T.; Korde, N.; Chung, D.; Dahi, P.; Landau, H.; Lahoud, O.; Hultcrantz, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • SETD1A function is mediated through interaction with mitotic regulators BuGZ/BUB3 in leukemia
    Meeting Abstract

    Hoshii, T.; Perlee, S.; Kikuchi, S.; Nakadai, T.; Masuda, T.; Ohtsuki, S.; Matsumoto, M.; Rahumtulla, B.; Fukuyo, M.; Cifani, P.; more...
    Experimental Hematology (2023)

    Fulltext@MSK | Save